Trial Profile
Intra-articular Treatment With MEN16132 in Patients With Symptomatic Primary Osteoarthritis of the Knee: A Randomized, Multi-centre, Double Blind, Placebo Controlled, Five Parallel Group, Dose Finding Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Oct 2021
Price :
$35
*
At a glance
- Drugs Fasitibant chloride (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Acronyms ALBATROSS
- 05 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Mar 2011 Results are expected in the second quarter of 2011.
- 12 Nov 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.